Health Utilities Index Mark 3 Demonstrated Construct Validity in a Population-based Sample with Type 2 Diabetes
Overview
Affiliations
Objective: To assess the cross-sectional construct validity of the Health Utilities Index mark 3 (HUI3) in type 2 diabetes using population health survey data.
Study Design And Setting: Data used were from 5,134 adult respondents of Cycle 1.1 (2000-2001) of the Canadian Community Health Survey (CCHS) with type 2 diabetes. Analyses of covariance models were used to assess differences in overall and single-attribute HUI3 scores between groups hypothesized a priori to differ in HRQL. The association between health-care resource use (i.e., hospitalizations and physician and emergency room visits) and overall HUI3 scores was assessed using logistic regression models.
Results: For overall HUI3 scores, clinically important and statistically significant differences were observed between all groups expected to differ in HRQL. Depression was the comorbidity associated with the largest deficit (-0.17; 95% confidence interval CI=-0.22, -0.12), followed by stroke (-0.15; 95% CI=-0.21, -0.10) and heart disease (-0.08; 95% CI=-0.11, -0.05). Insulin use and comorbidities were associated with clinically important deficits in pain. Overall HUI3 scores were significantly predictive of all three categories of health-care resource use.
Conclusion: Observed differences between groups contribute further evidence of the construct validity of the HUI3 in type 2 diabetes.
Wang Y, Xu Y, Shan H, Pan H, Chen J, Yang J Health Qual Life Outcomes. 2024; 22(1):74.
PMID: 39244536 PMC: 11380328. DOI: 10.1186/s12955-024-02288-1.
Ullah M, Cevallos A, Shen S, Carver C, Dunham R, Marsiglia D Front Neurosci. 2023; 17:1247269.
PMID: 37877013 PMC: 10591100. DOI: 10.3389/fnins.2023.1247269.
Langendoen-Gort M, Groeneveld L, Prinsen C, Beulens J, Elders P, Halperin I Rev Endocr Metab Disord. 2022; 23(5):931-977.
PMID: 35779199 PMC: 9515038. DOI: 10.1007/s11154-022-09734-9.
Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review.
Wee P, Kwan Y, Loh D, Phang J, Puar T, Ostbye T J Med Internet Res. 2021; 23(8):e25002.
PMID: 34397387 PMC: 8398743. DOI: 10.2196/25002.
Feeny D, Garner R, Bernier J, Thompson A, McFarland B, Huguet N J Phys Act Health. 2013; 11(7):1265-75.
PMID: 24176861 PMC: 4358805. DOI: 10.1123/jpah.2012-0268.